These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 38659344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Engineering Escherichia coli for high-level production of lacto-N-fucopentaose I by stepwise de novo pathway construction.
    Li Z, Zhu Y, Huang Z, Zhang P, Zhang W, Mu W.
    Carbohydr Polym; 2023 Sep 01; 315():121028. PubMed ID: 37230628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.
    Baumgärtner F, Seitz L, Sprenger GA, Albermann C.
    Microb Cell Fact; 2013 May 01; 12():40. PubMed ID: 23635327
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli.
    Lee WH, Pathanibul P, Quarterman J, Jo JH, Han NS, Miller MJ, Jin YS, Seo JH.
    Microb Cell Fact; 2012 Apr 30; 11():48. PubMed ID: 22545760
    [Abstract] [Full Text] [Related]

  • 8. High-Level De Novo Biosynthesis of 2'-Fucosyllactose by Metabolically Engineered Escherichia coli.
    Liu Y, Zhu Y, Wan L, Chen R, Zhang W, Mu W.
    J Agric Food Chem; 2022 Jul 27; 70(29):9017-9025. PubMed ID: 35834320
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enzymatic synthesis of lacto-N-difucohexaose I which binds to Helicobacter pylori.
    Miyazaki T, Sato T, Furukawa K, Ajisaka K.
    Methods Enzymol; 2010 Jul 27; 480():511-24. PubMed ID: 20816225
    [Abstract] [Full Text] [Related]

  • 14. Metabolic engineering of Escherichia coli to produce 2'-fucosyllactose via salvage pathway of guanosine 5'-diphosphate (GDP)-l-fucose.
    Chin YW, Seo N, Kim JH, Seo JH.
    Biotechnol Bioeng; 2016 Nov 27; 113(11):2443-52. PubMed ID: 27217241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic engineering of Escherichia coli for the production of 2'-fucosyllactose and 3-fucosyllactose through modular pathway enhancement.
    Huang D, Yang K, Liu J, Xu Y, Wang Y, Wang R, Liu B, Feng L.
    Metab Eng; 2017 May 27; 41():23-38. PubMed ID: 28286292
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.